## **Core Concept**
Myasthenia gravis (MG) is a chronic autoimmune disorder characterized by weakness and rapid fatigue of the muscles under voluntary control. It is caused by an abnormal immune response that disrupts the communication between nerves and muscles. The disease involves the formation of autoantibodies against specific components of the neuromuscular junction.

## **Why the Correct Answer is Right**
The correct answer, **nicotinic acetylcholine receptor (AChR)**, is the target of autoantibodies in myasthenia gravis. These antibodies are directed against the postsynaptic nicotinic acetylcholine receptors at the neuromuscular junction, leading to a decrease in the number of functional receptors. This reduction impairs the effective transmission of nerve impulses to muscles, resulting in muscle weakness and fatigue. The nicotinic AChR is crucial for muscle contraction as it facilitates the influx of sodium ions into the muscle cell, initiating muscle contraction.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While muscle-specific kinase (MuSK) is indeed involved in the pathogenesis of myasthenia gravis, antibodies against MuSK are found in a subset of patients (about 7-10%) who are often seronegative for AChR antibodies. MuSK is important for clustering AChR during neuromuscular junction formation, but it is not the primary target in the majority of MG cases.
- **Option B:** Voltage-gated calcium channels are targeted by autoantibodies in Lambert-Eaton myasthenic syndrome (LEMS), a different disorder from myasthenia gravis. LEMS is characterized by muscle weakness, but it typically presents with autonomic dysfunction and is associated with small cell lung cancer.
- **Option C:** There is no commonly recognized autoantigen in myasthenia gravis that matches this description, making it an incorrect option.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that myasthenia gravis can be associated with thymic abnormalities, including thymic hyperplasia and thymoma. In fact, a significant proportion of patients with myasthenia gravis have thymic hyperplasia, and some have thymomas. This association is relevant for both diagnosis and treatment planning, as thymectomy may be considered in certain cases.

## **Correct Answer:** D. nicotinic acetylcholine receptor.